Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We hereby inform you that the Company has issued notification to its designated employees and Directors regarding closure of trading window for them for the purposes of consideration and approval of the unaudited financial results for the quarter ended on June 30, 2019. The trading window would remain closed from July 1, 2019 until 48 hours from the declaration of the unaudited financial results. Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Sujay Wasan has been appointed as Additional (Non-Executive) Director of the Company subject to and effective from date of allotment of Director Identification Number (DIN). Mr. Sujay Wasan is not related to any Director of the Company. Brief profile of Mr. Sujay Wasan is given below: Mr. Sujay Wasan holds an International Masters in Business Administration degree (MBA) from The Netherlands. Mr. Sujay Wasan is the Vice President-Asia, India, Middle East and Africa, Personal Healthcare and Oral care, Asia Pacific and has lived and worked across Western Europe, North America and Asia with rich brand building experience across multiple core categories in critical global, regional and country roles. Mr. Sujay Wasan has spent the last 15 years with P&G; with assignments spanning global marketing and strategy for multi-billion dollar brands, designing breakthrough innovation, category marketing, and country operations with focus on purpose led marketing programs, digital and store-back marketing. Mr. Sujay Wasan is not debarred or disqualified from holding the office of Director by virtue of any order from SEBI / MCA or any such statutory authority. Kindly take the same on record. Procter & Gamble Health Ltd - 500126 - Corrigendum To Annual Report For Financial Year Ended December 31, 2018
We refer to our letter dated May 7, 2019, enclosing therewith Annual Report for the Financial Year ended December 31, 2018. We would like to inform you that the Company missed printing a letter forming part of the Secretarial Audit Report (Form MR-3) which is Annexure IV to the Annual Report for Financial Year ended December 31, 2018. We are enclosing herewith the said letter which will be treated as a part of the Secretarial Audit Report (Form MR-3) for Financial Year ended December 31, 2018. Procter & Gamble Health Ltd - 500126 - Annual Report For The Financial Year Ended December 31, 2018
We had submitted Annual Report of the Company for the Financial Year ended December 31, 2018 on May 7, 2019 to the Stock Exchange(s). We are again submitting a copy of Annual Report of the Company for the Financial Year ended December 31, 2018. Procter & Gamble Health Ltd - 500126 - Email ID For Investors And Website Address Of The Company
We would like to inform you that the email ID of the Company for the investors has been changed to investorgrievance.im@pg.com. Further, we would like to inform you that the website of the Company has been changed to www .pghealthindia.com. We request to take the same on record and update the same on the website of the Stock Exchange. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by a shareholder about the loss of the share certificates detailed in attached letter. We request you to take the same on record and acknowledge the receipt. MERCK LTD. - 500126 - Announcement under Regulation 30 (LODR)-Change in Directorate
We refer to our letter dated May 10, 2019, informing that Mr. Aalok Agrawal had been appointed as an Additional Director of the Company effective June 1, 2019, subject to allotment of Director Identification Number. We would like to inform you that Mr. Aalok Agrawal has been allotted DIN 08468145 by the Ministry of Corporate Affairs on May 30, 2019. Consequently, Mr. Aalok''s appointment as an Additional Director (Non-Executive) is effective from June 1, 2019. MERCK LTD. - 500126 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Merck Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here MERCK LTD. - 500126 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We would like to inform you that the 52nd Annual General Meeting of the Company was held on May 31, 2019 at 3.00 pm, at Sunville Banquets, 3rd Floor, Royal Room, Dr. Annie Besant Road, Worli, Mumbai 400 018. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizers Report Merck Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We would like to inform you that the 52nd Annual General Meeting of the Company was held on May 31, 2019 at 3.00 pm. at Sunville Banquets, 3rd Floor, Royal Room, Dr. Annie Besant Road, Worli, Mumbai 400 018. In this respect, please find enclosed a summary of proceedings of the 52nd Annual General Meeting,